Nabi Biopharmaceuticals nabi.com


has a broad product portfolio that modulates the immune system. Their research focuses on developing and commercializing novel vaccines and antibody-based therapies that prevent and treat infectious, autoimmune and addictive diseases, such as Staphylococcus aureus and hepatitis infections, and nicotine addiction.

has a broad product portfolio that modulates the immune system. Their research focuses on developing and commercializing novel vaccines and antibody-based therapies that prevent and treat infectious, autoimmune and addictive diseases, such as Staphyl...Show all

Company (Alive / Active)

Phone: 301-770-3099

Fax:

12276 Wilkins Avenue

Rockville, 20852
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Nabi Biopharmaceuticals $33.5M Jul 4, 2003
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Nabi Biopharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Bayhill Therapeutics

San Mateo, California, United States
Dead / InactiveBayhill Therapeutics Inc. is a clinical-stage biotechnology company focused on developing and commercializing therapeutics that fundamentally alter the way autoimmune diseases are treated. The company has developed two therapeutic platforms with broad applicability to a range of autoimmune diseases. Bayhill's BHT-DNA autoimmune vaccine is designed to eliminate disease-causing cells without effecting normal protective immune system cells. BHT-DNA is being studied in a Phase II trial for multiple ...Show allLogin to see details

BioVex

Woburn, Massachusetts, United States
AcquiredBioVex is a biotechnology company that develops vaccines. The company develops vaccines for the treatment of cancer and chronic infectious diseases. BioVex has two proprietary vaccine platforms; OncoVEX and ImmunoVEX, and a functional genomics platform for gene target validation in neurons and other tissues.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Smoking cessation kit and method Jun 09, 2009 Jul 31, 2012 Patent
Hapten-carrier conjugates for treating and preventing nicotine addiction Jul 14, 2010 Sep 27, 2011 Patent
Hapten-carrier conjugates for treating and preventing nicotine addiction Jul 20, 2007 Aug 17, 2010 Patent
Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women Feb 26, 2007 Jun 16, 2009 Patent
Untitled Dec 20, 2004 May 12, 2009 Patent